Pure Global

PYROFEN 250 MG/5 ML ORAL SUSPENSION, 150 ML - Turkey License d415c8a4888883d270dae36e14f6e3ea

Access comprehensive regulatory information for PYROFEN 250 MG/5 ML ORAL SUSPENSION, 150 ML in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number d415c8a4888883d270dae36e14f6e3ea with license number 2022/786and contains active ingredient Parasetamol . The license is held by DEVA HOLDฤฐNG A.ลž..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
d415c8a4888883d270dae36e14f6e3ea
License Details
Turkey SFDA License: d415c8a4888883d270dae36e14f6e3ea
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

PYROFEN 250 MG/5 ML ORAL SUSPENSION, 150 ML
TR: PฤฐROFEN 250 MG/5 ML ORAL SรœSPANSฤฐYON, 150 ML
Pharmaceutical Product

License Details

d415c8a4888883d270dae36e14f6e3ea

2022/786

8699525707710

N02BE01

License Holder Information

Active Ingredient

Parasetamol

License Information

Dec 22, 2022